Johnson & Johnson is putting its money where its mouth is, investing $100 million in a fund that aims to make a difference in the lives of women, children, and adolescents around the world, the New York Times reports.
The Women's and Children's Health Technology Fund, or CBIV, is a partnership between Johnson & Johnson's philanthropic arm, the Johnson & Johnson Foundation, and Germany's state-owned financial institution, KfW.
According to a press release, the fund will invest in technology companies that "make health systems more resilient" or "address women's, children's, and adolescents' or make health systems more accessible."
Companies in CBIV's portfolio include Daye, which has created a tampon-based diagnostic platform for conditions such as cervical cancer; Onco Health, which provides digital health platform for cancer patients; and OCIO Bivium Westfuller, which provides neonatal ultrasound services.
"Our current portfolio has the potential to make a difference in the lives of millions of women, children, and adolescents in North America and Europe, in addition to targeting underserved populations in emerging markets," Donna Parr, a managing partner at CBIV, says in the press release.
Read the Entire Article
A customized collection of news from foundations from around the Web.
HootSuite CEO Ryan Holmes says “…social tools are getting more broadly adopted across organizations. It’s not just marketing anymore, it’s sales, public relations, human relations, everywhere.”